# Urokinase

## UROKINASE 60，000IU (綠十字)

| TAH Drug Code      | [IURO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IURO)                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Acute coronary embolism， clearance of occluded catheters & shunts， acute pulmonary embolism， peripheral arterial or venous thromboembolism.                                                                                                                                                                                                                                                                                                              |
| Dosing             | Cerebral thrombosis (within 5 days after onset of symptoms & without hemorrhage) 60，000 iu once daily for 7 days. Peripheral arterial/venous occlusion 60，000 to 240，000 iu on first day of treatment followed by tapered doses for about 7 days. Acute coronary embolism 26，000-52，000 iu daily for 7 days. Deep vein thrombosis or acute pulmonary embolism IV loading 250，000 iu/hr， then 1，000 iu/kg/hr (or 60，000 -100，000 iu/hr) for 72 hr. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Intracranial hemorrhage， hemoptysis， difficulty in hemostatic management; undergone intracranial or spinal surgery or with such injury (in the last 2 months); aneurysm; serious disturbance of consciousness.                                                                                                                                                                                                                                            |
| Adverse Effects    | Bleeding tendency. Fever， chills， headache & malaise may occur. Rarely， shock， sweating， disturbed pulse & dyspnea; rash， urticaria;nausea; vomiting & anorexia; abnormal liver function test; hematuria. Hematologic: Decreased hematocrit level (37%)                                                                                                                                                                                               |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/urokinase-drug-information)                                                                                                                                                                                                                                                                                                                                                                                    |

